Medinice S.A. logo

Medinice S.A. (77E)

Market Closed
11 Jun, 07:14
XFRA XFRA
19. 12
-0.44
-2.2495%
- Market Cap
- P/E Ratio
- Div Yield
250 Volume
0 Eps
19.56
Previous Close
Add Transaction
Day Range
19.12 19.12
Year Range
9.61 21.55
Want to track 77E and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

77E closed yesterday lower at €19.12, a decrease of -2.2495% from Wednesday's close, completing a monthly increase of 17.8792% or €2.9. Over the past 12 months, 77E stock gained 98.9594%.
77E is not paying dividends to its shareholders.
The last earnings report, released on Jun 03, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0943%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on WSE (PLN).

77E Chart

Medinice S.A. (77E) FAQ

What is the stock price today?

The current price is €19.12.

On which exchange is it traded?

Medinice S.A. is listed on XFRA.

What is its stock symbol?

The ticker symbol is 77E.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Medinice S.A. ever had a stock split?

No, there has never been a stock split.

Medinice S.A. Profile

- Industry
- Sector
Mr. Sanjeev Choudhary CEO
XFRA Exchange
PLMDNCE00016 ISIN
PL Country
11 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Medinice S.A. is a medical technology company that specializes in creating, developing, and commercializing minimally invasive solutions in the fields of cardiology and cardiac surgery. Based in Warsaw, Poland, the company was founded in 2012 and has established itself in the market by providing innovative medical devices aimed at improving patient outcomes and reducing the risk of complications associated with cardiac procedures.

Products and Services

  • PacePress

    PacePress is a medical device designed to minimize the risk of complications after the implantation of cardiac electrotherapeutic devices, such as pacemakers and implantable cardioverter-defibrillators. Its innovative design enhances patient safety during these critical procedures.

  • CoolCryo

    CoolCryo is a cutting-edge cardiac cryoablation technology that utilizes liquid nitrogen as the cooling medium. This technology is crucial for effectively targeting and treating abnormal heart rhythms through precise cryoablation techniques.

  • AtriClamp

    AtriClamp is a specialized clip designed for closing the left atrial appendage, helping to significantly reduce the risk of stroke in patients suffering from atrial fibrillation. This product is an important advancement in enhancing the safety of cardiac patients.

  • MiniMax

    MiniMax is an ablation-mapping catheter that facilitates the detection of intracardiac electrophysiological signals. It allows for the creation of a three-dimensional map of the heart, enabling clinicians to perform intracardiac irrigated radiofrequency ablation for treating arrhythmias caused by conduction system abnormalities.

  • EP Bioptom

    EP Bioptom is an advanced electrode designed for endomyocardial biopsy procedures. This device leverages 3D mapping technology, allowing healthcare professionals to conduct simultaneous biopsies while creating a comprehensive three-dimensional heart map for better diagnostic accuracy.

Contact Information

Address: Hankiewicza St. 2, Warsaw, Poland, 02-103
Phone: 48 725 50 00 51